Fabio Presotto

Fabio Presotto

Auto-generated profile, based on publicly available information

Fabio Presotto

Department of Internal Medicine, Ospedale dell’Angelo, Mestre-Venezia, Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1997 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
CBCorrado Bestterle
Corrado Bestterle
MVMarina Volpato
Marina Volpato
BSBernard Rees Smith
Bernard Rees Smith
JFJadwiga Furmaniak
Jadwiga Furmaniak
SCShu Chen
Shu Chen
FPFabio Presotto
Fabio Presotto
Adrenal cortex autoantibodies (ACA) were measured by immunofluorescence in 808 children with organ-specific autoimmune diseases without adrenal insufficiency. ACA were found in 14 children (1.7%), mostly in hypoparathyroidism (48%). Ten ACA-positive and 12 ACA-negative children were followed up for a maximum of 10 yr by evaluation of adrenocortical function (ACTH test) and autoantibody status. In all patients steroid-producing cell autoantibodies were assessed by immunofluorescence and autoantibodies to steroid 21-hydroxylase, 17α-hydroxylase, and cytochrome P450 side-chain cleavage enzyme by immunoprecipitation assay. All 10 ACA-positive patients were positive for 21-hydroxylase autoantibodies. Six were positive for steroid-producing cell autoantibodies and 5 also for autoantibodies to 17α-hydroxylase and/or P450 side-chain cleavage enzyme. Overt Addison’s disease developed in 9 (90%) ACA/21-OH-antibody-positive children after 3–121 months, and 1 remaining child had subclinical hypoadrenalism. By contrast, all ACA/21-OH antibody-negative children maintained normal adrenal function. Adrenal failure was not related to ACA titres, sex, adrenal function, type of preexisting autoimmune disorder, or human leucocyte antigens D-related status. In conclusion, in children with autoimmune endocrine diseases, ACA/21-hydroxylase autoantibodies are important predictive markers for the development of Addison’s disease.

2 May 2022 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
PDF file
MGMariella Giannone
Mariella Giannone
MCMiriam Dalla Costa
Miriam Dalla Costa
CSChiara Sabbadin
Chiara Sabbadin
SGSilvia Garelli
Silvia Garelli
MSMonica Salvà
Monica Salvà
CBCorrado Bestterle
Corrado Bestterle
Objectives: The reported prevalence of TSH-receptor (TSHR) autoantibodies (TRAb) in patients with chronic thyroiditis (CT) range from 0 to 48%. The objective was to study the prevalence of TRAb in patients with CT and hypothyroidism and to correlate it with gender, age, thyroid dimensions, TSH levels, and autoimmune diseases. Methods: The study comprised 245 patients with CT and hypothyroidism (median age 42 years, 193 females, 52 males) and 123 Italian healthy subjects matched for sex and age as controls. TRAb were tested with ELISA using a >2.5 IU/L cut off for positivity. TSHR blocking (TBAb) and TSHR stimulating autoantibodies (TSAb) were measured in 12 TRAb-positive patients using bioassays with Chinese hamster ovary (CHO) cells expressing wild-type or R255D-mutated TSHR. Results: TRAb positivity was found in 32/245 (13.1%) patients and significantly correlated (p45 years of age (p<0.05) and in patients with reduced vs. normal/increased thyroid dimensions (p<0.05). Linear regression analysis showed a correlation between TRAb concentrations with age (p<0.05) and TRAb concentrations with TSH (p<0.01). In bioassay with TSHR-R255D all 12 patients tested were TBAb-positive while 33% were also TSAb-positive suggesting the presence of a mixture of TRAbs with different biological activities in some patients. Conclusions: TRAb have been found in patients with CT and hypothyroidism. A mixture of TBAb and TSAb was found in some patients and this may contribute to the pathogenesis of thyroid dysfunction during the course of the disease.

29 December 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
NCNicola Cavasin
Nicola Cavasin
FPFabio Presotto
Fabio Presotto
MBMatteo Bellamio
Matteo Bellamio
ECEnrico Cagliari
Enrico Cagliari
Thyroid-associated ophthalmopathy (TAO) is a well-known and frequent epiphenomenon of a hyperthyroid autoimmune disease that can present with proptosis, strabismus, and diplopia. Ophthalmopathy can occur in the absence of overt Graves’ disease, even in euthyroid patients. Cavernous sinus dural fistulas (CS-DAVF) are abnormal communications between the cavernous sinus (CS) and dural branches from internal carotid or external carotid arteries. They can often present with ocular symptoms that can mimic a thyroid-associated ophthalmopathy. CS-DAVF are usually successfully treated with an endovascular embolization that can be pursued both through a transvenous or transarterial approach. TAO and CS-DAVF can coexist especially when the ocular symptoms are unilateral. In those cases, an endovascular embolization is usually curative, but sometimes the procedure can fail. Our hypothesis is that some cases of CS-DAVF may be of secondary nature (i.e., caused by compression of the venous outlet by the hypertrophic ocular muscles); therefore, treating the ocular disease with medical therapy may solve the vascular problem as well. We present a case of a CS-DAVF in a patient with TAO successfully treated with sole medical therapy after the failure of a first-line endovascular treatment.

1 September 2024 in Vasa
Verified
Journal Article
Closed access
MVMichele Dalla Vestra
Michele Dalla Vestra
MZMarta Zanon
Marta Zanon
EGElisabetta Grolla
Elisabetta Grolla
ATAndrea Tavernese
Andrea Tavernese
GAGiuliana Autiero
Giuliana Autiero
FPFabio Presotto
Fabio Presotto

1 January 2024
Verified
Book Chapter
Closed access
PDF file
CBCorrado Bestterle
Corrado Bestterle
CSChiara Sabbadin
Chiara Sabbadin
JFJadwiga Furmaniak
Jadwiga Furmaniak
FPFabio Presotto
Fabio Presotto